BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1081 related articles for article (PubMed ID: 26944243)

  • 1. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
    Marur S; Forastiere AA
    Mayo Clin Proc; 2016 Mar; 91(3):386-96. PubMed ID: 26944243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of basaloid squamous cell carcinoma in head and neck cancer.
    Linton OR; Moore MG; Brigance JS; Gordon CA; Summerlin DJ; McDonald MW
    JAMA Otolaryngol Head Neck Surg; 2013 Dec; 139(12):1306-11. PubMed ID: 24158536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
    Ramos M; Benavente S; Giralt J
    Expert Rev Anticancer Ther; 2010 Mar; 10(3):339-44. PubMed ID: 20214515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer: changing epidemiology, diagnosis, and treatment.
    Marur S; Forastiere AA
    Mayo Clin Proc; 2008 Apr; 83(4):489-501. PubMed ID: 18380996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contemporary management of head and neck cancers.
    Gil Z; Fliss DM
    Isr Med Assoc J; 2009 May; 11(5):296-300. PubMed ID: 19637508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
    Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective neck dissection following adjuvant therapy for advanced head and neck cancer.
    Mukhija V; Gupta S; Jacobson AS; Eloy JA; Genden EM
    Head Neck; 2009 Feb; 31(2):183-8. PubMed ID: 19031407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent changes in the epidemiology of head and neck cancer.
    Curado MP; Hashibe M
    Curr Opin Oncol; 2009 May; 21(3):194-200. PubMed ID: 19363341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head and neck cancer: past, present and future.
    Chin D; Boyle GM; Porceddu S; Theile DR; Parsons PG; Coman WB
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):1111-8. PubMed ID: 16831082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment of head and neck squamous cell cancer.
    Belcher R; Hayes K; Fedewa S; Chen AY
    J Surg Oncol; 2014 Oct; 110(5):551-74. PubMed ID: 25053506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of treatment outcomes by radiochemotherapy and postoperative radiotherapy in locally advanced squamous cell carcinomas of head and neck.
    Fortin A; Caouette R; Wang CS; Vigneault E
    Am J Clin Oncol; 2008 Aug; 31(4):379-83. PubMed ID: 18845998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term results of the combined modality therapy for advanced cervical metastatic head and neck squamous cell carcinoma.
    Preuss SF; Klussmann JP; Wittekindt C; Damm M; Semrau R; Drebber U; Guntinas-Lichius O
    Eur J Surg Oncol; 2007 Apr; 33(3):358-63. PubMed ID: 17157472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of head and neck cancer patients referred to an oral and maxillofacial surgeon in the United States for management.
    Holmes JD; Martin RA; Gutta R
    J Oral Maxillofac Surg; 2010 Mar; 68(3):555-61. PubMed ID: 20171475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck cancers: a clinico-pathological profile and management challenges in a resource-limited setting.
    Gilyoma JM; Rambau PF; Masalu N; Kayange NM; Chalya PL
    BMC Res Notes; 2015 Dec; 8():772. PubMed ID: 26654449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II feasibility trial of adjuvant chemoradiotherapy with 3-weekly cisplatin for Japanese patients with post-operative high-risk squamous cell carcinoma of the head and neck.
    Kiyota N; Tahara M; Okano S; Kawashima M; Matsuura K; Onozawa Y; Nibu K; Hayashi R; Yoshimura K; Ohtsu A
    Jpn J Clin Oncol; 2012 Oct; 42(10):927-33. PubMed ID: 22923484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special groups: head and neck cancer.
    Arrese LC; Lazarus CL
    Otolaryngol Clin North Am; 2013 Dec; 46(6):1123-36. PubMed ID: 24262964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Imaging in head and neck cancers].
    Iannessi A; Ouvrier MJ; Thariat J; Marcy PY
    Bull Cancer; 2014 May; 101(5):469-80. PubMed ID: 24886898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular targeted therapies in all histologies of head and neck cancers: an update.
    Razak AR; Siu LL; Le Tourneau C
    Curr Opin Oncol; 2010 May; 22(3):212-20. PubMed ID: 20173639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of bone or cartilage invasion of locally advanced head and neck cancers.
    Do L; Syed N; Puthawala A; Azawi S; Williams R; Vora N
    Am J Clin Oncol; 2010 Dec; 33(6):591-4. PubMed ID: 20065851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.